CDT Equity Inc.

Contributing Author

Recent Articles by CDT Equity Inc.

Oct-30	CDT Equity Welcomes U.S. Regulatory Development Supporting Expanded Access to Compounded Peptides CDT -11.69% GlobeNewswire
Oct-27	CDT Partners with Manoira to Explore Enhancing Animal Health Products Ahead of Launch CDT -14.89% GlobeNewswire
Oct-14	CDT Highlights Sarborg's Solid-Form Patent Filing on a First-in-Class Respiratory Asset CDT -46.67% GlobeNewswire
Sep-29	CDT Highlights Sarborg's Expanding Quantum Computing IP Portfolio and Application to Drug Discovery CDT -23.68% GlobeNewswire
Sep-25	CDT Equity Inc. Announces Reverse Stock Split CDT -33.88% GlobeNewswire
Sep-18	CDT Partners with QIMA Life Sciences to Evaluate Novel Tapinarof Combinations in Psoriasis and Vitiligo CDT -8.18% GlobeNewswire
Sep-10	CDT Highlights Sarborg's Application of Signature Intelligence and Quantum Computing Models to Mental Health CDT -42.54% GlobeNewswire
Sep-02	CDT Provides Capital Update and Confirms No Nasdaq Deficiencies CDT -38.51% GlobeNewswire
Sep-01	CDT Appoints Co-Founder James Bligh as Chief Executive Officer to Lead Next Phase of Growth CDT -11.90% GlobeNewswire
Aug-28	CDT Validates Enhanced Solid-Form Properties Within Its IP Portfolio CDT -10.11% GlobeNewswire
Aug-25	CDT Announces Investment in Pep'd, Expanding into the Fast-Growing US Peptide Market CDT -17.67% GlobeNewswire
Aug-03	CDT Increases Stake in Sarborg following its Quantum Computing and Intellectual Property Expansion CDT GlobeNewswire
Jul-20	CDT Highlights Sarborg's Patent Filing Extending Quantum-Enabled PRISM Platform to Sugarcane CDT +13.75% GlobeNewswire
Jul-16	CDT Equity Inc. Announces Reverse Stock Split CDT GlobeNewswire
Jun-26	CDT Highlights Sarborg's Application of Quantum Computing to Solid-Form Development CDT -10.81% GlobeNewswire
Jun-18	CDT Notes Strategic Investment into Sarborg and Expansion into Quantum Computing CDT +47.19% GlobeNewswire
Jun-16	CDT Equity Announces Debt Update and New Loan Facility CDT GlobeNewswire
May-28	CDT Equity Inc. Announces Receipt of Nasdaq Deficiency Letter CDT -13.63% CDT +9.46% GlobeNewswire
May-27	CDT Announces Canadian Patent for AZD5904 in Male Infertility CDT +24.39% GlobeNewswire
May-07	CDT Notes Sarborg Filing of Substance of Matter Patent in Cystic Fibrosis Market CDT -7.96% GlobeNewswire
May-06	CDT Advances AZD5904 into Global Patent Phase and Initiates Partnering Discussions CDT +8.65% GlobeNewswire
Apr-16	CDT Expands Multi-Pathway Value Creation Strategy Across Pharma, IP and AI-Driven Discovery CDT -24.41% GlobeNewswire
Apr-07	CDT Notes Sarborg Publication of PRISM Framework Expanding AI CDT +6.84% GlobeNewswire
Mar-26	CDT Equity Expands Tapinarof Intellectual Property Portfolio with Two New Patent Filings CDT -9.61% GlobeNewswire
Mar-25	CDT Equity Inc. Announces Reverse Stock Split CDT -12.00% GlobeNewswire
Mar-23	CDT Identifies Rare Disease Opportunities Through Sarborg Signature Analysis, Advancing Out-Licensing Strategy CDT GlobeNewswire
Mar-18	CDT Equity Stockholders Approve All Proposals at Special Meeting, Positioning the Company for Next Phase of Growth CDT GlobeNewswire
Mar-12	CDT Notes Sarborg Expansion into Rare Disease Signature Intelligence CDT GlobeNewswire
Mar-05	CDT Equity Notes Sarborg Filing of U.S. Provisional Patent Application for AI Signature Agent CDT -5.80% GlobeNewswire
Mar-04	CDT Positions for Transformational Growth CDT +14.23% GlobeNewswire
Feb-24	CDT Equity Notes Sarborg Expansion into Bacteria and Agrochemicals CDT GlobeNewswire
Feb-20	CDT Acquires Strategic Stake in Sarborg to Transform its AI-Driven Asset Strategy CDT -19.29% GlobeNewswire
Jan-02	CDT Engages NJS Foresight Bio-Advisory to Support Solid-Form Out-Licensing Strategy CDT +12.50% GlobeNewswire
Oct-17	CDT Equity Increases Bitcoin Holding CDT GlobeNewswire
Oct-09	CDT Equity Inc. Announces Reverse Stock Split CDT -11.92% GlobeNewswire
Sep-17	CDT Executes Cryptocurrency Treasury Reserve Strategy CDT +40.10% GlobeNewswire
Sep-03	CDT Board Authorizes Adoption of Cryptocurrency Treasury Reserve Strategy CDT -9.77% GlobeNewswire
Aug-26	CDT Equity Identifies New Biological Target Validating AI-Driven Repurposing Strategy CDT -10.42% GlobeNewswire

CDT Equity Inc.

Recent Articles by CDT Equity Inc.

Upgrade your Finviz experience